Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2020 07:00 ET | Source: Codexis, Inc.

Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders

REDWOOD CITY, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the signing of a strategic...
February 27, 2020 16:05 ET | Source: Codexis, Inc.

Codexis Reports 2019 Fourth Quarter and Full Year Financial Results

2019 total revenues increased 13% to $68.5 million with product revenue up 15% and R&D revenue up 11% Ten customers contributed more than $1 million each to 2019 revenues Introduces...
February 25, 2020 07:00 ET | Source: Codexis, Inc.

Codexis to Present at Two Investment Conferences in March

REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
February 20, 2020 07:00 ET | Source: Codexis, Inc.

Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27

REDWOOD CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2019 fourth quarter and full year financial...
January 13, 2020 16:05 ET | Source: Codexis, Inc.

Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing

CHONGQING, China, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) today announced that it has attended the official opening of Porton Pharma Solutions Ltd.’s (SZSE: 300363)...
January 10, 2020 07:00 ET | Source: Codexis, Inc.

Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement

REDWOOD CITY, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer of novel biotherapeutics, and Nestlé Health Science, a...
December 23, 2019 07:00 ET | Source: Codexis, Inc.

Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing

REDWOOD CITY, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA...
December 05, 2019 16:05 ET | Source: Codexis, Inc.

Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir

REDWOOD CITY, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the publication with Merck, known as MSD outside the United...
November 05, 2019 16:05 ET | Source: Codexis, Inc.

Codexis Reports Third Quarter 2019 Financial Results

Total revenues rose 29% to $21.9 million driven by strength in R&D, product, and CodeEvolver® licensing revenues Eleven customers each contributed at least a quarter million dollars in revenue ...
November 05, 2019 07:00 ET | Source: Codexis, Inc.

Codexis to Participate in Four Investment Conferences in November

REDWOOD CITY, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in four upcoming investment...